Expert brings insights, history, strong opinions to NSF controversy

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 30 No 12
Volume 30
Issue 12

John C. Hayes is editor of Diagnostic Imaging.

Sometimes we get to explore a controversy with a bit of historical perspective. That opportunity usually involves someone who has spent considerable time in radiology and has developed strong opinions about what the history shows. We have just such an example in a commentary from Prof. Dr. Peter Rinck that appears on page 23 of this edition.

Rinck, an expert in MR contrast, looks at the association of nephrogenic systemic fibrois and gadolinium. Probably better than anyone else, Rinck has the clinical and scientific knowledge, along with the business perspective, that allows him to reach some interesting conclusions about how this problem came about.

Some of what he reports those of us who have followed the NSF controversy know already: for example, that cyclic agents are less likely to be associated with NSF than linear agents. But there is much here that is new and reflects Rinck's considerable experience in the field, including inside knowledge gained as an instructor who taught physicians and vendor representatives about the mechanisms of gadolinium contrast.

As is appropriate in this setting, Rinck also imparts lessons learned. Coming in for criticism is an industry that failed to heed some of the warning signs and, especially, radiologists who pursued off-label gadolinium uses without fully understanding the mechanisms at work.

Rinck's column is a provocative article and worth your attention.

John C. Hayes is editor of Diagnostic Imaging.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
Emerging Concepts in CT-Guided Treatment of Coronary Artery Disease
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Related Content
© 2025 MJH Life Sciences

All rights reserved.